CN1C(=O)[C@H]2[C@@H](C1=O)[C@@H](c1cccc(Br)c1)N1C(=O)c3ccccc3NC(=O)[C@@H]21
Orally active drug usually follows the rule of three, in which the molecular weight of a fragment is <300, the c Log P is ≤3, the number of hydrogen bond donors is ≤3 and the number of hydrogen bond acceptors is ≤3. The molecule meets rule of three or not?